NeoNavia® - A new biopsy system

Advances in breast cancer screening, imaging, and breast cancer treatments have created new demands for developing new technologies for tissue sampling in breasts and axillary lymph nodes. 

NeoDynamics is now introducing its new precision biopsy system, NeoNavia® for ultrasound-guided breast biopsies.

Read more about NeoNavia

One key innovation of our biopsy system is the technology for needle insertion through healthy tissue and exact placement in a suspicious lesion. The technology is patented and called pulse technology.

Read more about pulse technology

NeoDynamics AB (publ) is a Swedish medical technology company dedicated to advancing the diagnosis and care of breast cancer.

Read more about us

The NeoNavia® biopsy system can safely increase the precision of ultrasound-guided, technically challenging biopsies such as in axillary lymph nodes.1

Dr Steven Allen, Consultant Radiologist, Royal Marsden NHS Foundation Trust, UK
Would you like to test and evaluate NeoNavia?
Evaluate NeoNavia
1) J. Lee, B. Bishop, S. Allen; The Royal Marsden NHS Foundation Trust, London; Oxford University Hospitals NHS Foundation Trust, Oxford, UK; Published in Breast Cancer Research 2017, 19(Suppl 1):PB.39